Skip to main content
Clinical Trials/NCT01149538
NCT01149538
Completed
Phase 1

Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure

University of Minnesota1 site in 1 country60 target enrollmentJuly 2010

Overview

Phase
Phase 1
Intervention
Choline bitartrate
Conditions
Fetal Alcohol Spectrum Disorders
Sponsor
University of Minnesota
Enrollment
60
Locations
1
Primary Endpoint
Side Effects of Choline Bitartrate
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to determine if choline bitartrate can be administered daily to children with prenatal alcohol exposure, ages 2.5 to 5, as a potential treatment for brain development and cognitive functioning.

Registry
clinicaltrials.gov
Start Date
July 2010
End Date
September 2014
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Available parent or legal guardian capable of participating in informed consent process
  • Documented history of heavy prenatal alcohol exposure (self-report, social service records, or adoption records) or presence of facial dysmorphology characteristic of FASD or both
  • Evidence of cognitive deficit in at least one neurocognitive domain

Exclusion Criteria

  • History of neurological condition (ex. epilepsy, cerebral palsy, traumatic brain injury)
  • History of medical condition known to affect brain function
  • History of other neurodevelopmental disorder (ex. autism, down syndrome)
  • History of very low birthweight (\<1500 grams)
  • History of prenatal exposure to drugs other than alcohol, nicotine, and caffeine

Arms & Interventions

Choline Bitartrate

Choline Bitartrate supplementation

Intervention: Choline bitartrate

Placebo

Placebo for choline bitartrate supplementation

Intervention: Placebo for choline bitartrate

Outcomes

Primary Outcomes

Side Effects of Choline Bitartrate

Time Frame: Baseline, 6 months, & 9 months

Side effects of choline bitartrate will be monitored by the study physician and the P.I. with physical examinations and telephone contact.

Mullen Scales of Early Learning - Early Learning Composite

Time Frame: Baseline and 9 months

The Mullen Scales of Early Learning is a measure of global cognitive development and is a primary outcome measure. The Early Learning Composite is the total score for this measure. It is a scaled score with a mean of 100 and a standard deviation of 15 (higher scores indicate better global cognitive status; average range is 85-115; Impaired range is 70 or below; full range is typically 50 - 150, although minimum and maximum scores are dependent on age). See the Mullen Scales reference manual for more psychometric details.

Secondary Outcomes

  • Elicited Imitation Task Memory(Baseline, 6 months, and 9 months)
  • Evoked Response Potentials Microvolts(Baseline, 6 months, and 9 months)
  • Evoked Response Potential - Negative Component Latency(Baseline, 6 months, and 9 months)

Study Sites (1)

Loading locations...

Similar Trials